Skip to content

Intellicell Biosciences, Inc.

company.status.inactive

CIK 1125280fmd_1PMZFCV7XNKKGYADJW4ZXQ6MRYManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2011 to Sep 30, 2014, 15 periods

Latest annual · FY2013

Millions
Total revenues
0
Gross profit
0
Operating income
(6)
Net income
(16)
Free cash flow
(1)

Latest quarter · Q3 FY2014

Millions
Total revenues
0
Gross profit
0
Operating income
(1)
Net income
(3)
Free cash flow
(1)
Open Financials

Intellicell Biosciences, Inc. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2013FY2012ChangeSource
Revenue$0$534,942-100%10-K/A 2014-10-09 · proof
Gross profit$0$100,090-100%10-K/A 2014-10-09 · proof
Operating income-$5.5 million-$14.7 million10-K 2014-05-12 · proof
Net income-$15.9 million-$4.2 million10-K/A 2014-10-09 · proof
Cash from operating activities-$1.2 million-$1.1 million10-K 2014-05-12 · proof
Free cash flow-$1.4 million-$3.5 million10-K 2014-05-12 · proof
Total assets$3.2 million$3.5 million-9.5%10-K 2014-05-12 · proof
Total liabilities$15.5 million$7.7 million+101.6%10-K/A 2014-10-09 · proof
Cash and cash equivalents$0$10,159-100%10-Q 2014-06-18 · proof
What was Intellicell Biosciences, Inc.'s revenue in fiscal 2013?
Intellicell Biosciences, Inc. reported revenue of $0 for fiscal 2013 (the year ended Dec 31, 2013), against $534,942 the year before (-100%). Source: the 10-K/A filed with the SEC on Oct 9, 2014. SEC
What was Intellicell Biosciences, Inc.'s gross profit in fiscal 2013?
Intellicell Biosciences, Inc. reported gross profit of $0 for fiscal 2013 (the year ended Dec 31, 2013), against $100,090 the year before (-100%). Source: the 10-K/A filed with the SEC on Oct 9, 2014. SEC
What was Intellicell Biosciences, Inc.'s operating income in fiscal 2013?
Intellicell Biosciences, Inc. reported operating income of -$5.5 million for fiscal 2013 (the year ended Dec 31, 2013), against -$14.7 million the year before. Source: the 10-K filed with the SEC on May 12, 2014. SEC
What was Intellicell Biosciences, Inc.'s net income in fiscal 2013?
Intellicell Biosciences, Inc. reported net income of -$15.9 million for fiscal 2013 (the year ended Dec 31, 2013), against -$4.2 million the year before. Source: the 10-K/A filed with the SEC on Oct 9, 2014 (restated). SEC
What was Intellicell Biosciences, Inc.'s cash from operating activities in fiscal 2013?
Intellicell Biosciences, Inc. reported cash from operating activities of -$1.2 million for fiscal 2013 (the year ended Dec 31, 2013), against -$1.1 million the year before. Source: the 10-K filed with the SEC on May 12, 2014. SEC
What was Intellicell Biosciences, Inc.'s free cash flow in fiscal 2013?
Intellicell Biosciences, Inc. reported free cash flow of -$1.4 million for fiscal 2013 (the year ended Dec 31, 2013), against -$3.5 million the year before. Source: the 10-K filed with the SEC on May 12, 2014. SEC
What are Intellicell Biosciences, Inc.'s total assets?
As of Dec 31, 2013, Intellicell Biosciences, Inc. reported total assets of $3.2 million, against $3.5 million a year earlier (-9.5%). Source: the 10-K filed with the SEC on May 12, 2014. SEC
What are Intellicell Biosciences, Inc.'s total liabilities?
As of Dec 31, 2013, Intellicell Biosciences, Inc. reported total liabilities of $15.5 million, against $7.7 million a year earlier (+101.6%). Source: the 10-K/A filed with the SEC on Oct 9, 2014 (restated). SEC
What are Intellicell Biosciences, Inc.'s cash and cash equivalents?
As of Dec 31, 2013, Intellicell Biosciences, Inc. reported cash and cash equivalents of $0, against $10,159 a year earlier (-100%). Source: the 10-Q filed with the SEC on Jun 18, 2014. SEC

Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1125280&period_type=annual&limit=5"

Information only, not investment advice.